Frequency of micronuclei and other nuclear abnormalities in diabetic patients

Authors

  • Marcelo Torquato Toneline PUC-SP
  • Júlio Boschini Filho PUC-SP
  • Débora Aparecida Rodrigueiro PUC-SP
  • Neil Ferreira Novo PUC-SP

Keywords:

micronuclei, nuclear budding, diabetes, stress oxidative.

Abstract

ABSTRACT
Purpose: Diabetes mellitus is associated with development of vascular complications consequent to oxidative DNA damage. In the current study, we evaluated the formation of biomarkers of genotoxicity as micronucleation, budding nuclear, nuclear bridge, and other nuclear abnormalities in patients with type 2 diabetes. Methods: forty-five subjects were divided into two groups of normoglycemic controls and hyperglycemic (type 2 diabetes), were bandied about in the study. Epithelial cells of the oral mucosa were collected according to the international protocol of Thomas et al. and Bolognesi et al. All nuclear changes found were recorded, totaling analysis of 2,000 cells. This finding was correlated with age, sex, comorbidities, and drug consumption habits. Statistical analysis was performed using the Mann-Whitney test and chi-square test. Results: cells from diabetic patients showed an increased frequency of micronuclei (on average 4.7 per 2,000 cells compared with 2.0 in the control group, p < 0.001) and nuclear budding (average 6.3 per 2,000 cells against 4,1 control group, p < 0.05) when compared to the control group, indicating a higher DNA damage due to oxidative stress and possibly related vascular complications of diabetes. Conclusion: the high level of glucose in the blood appears to be involved with oxidative damage in the DNA of diabetic patients, manifested as an increase in micronuclei and nuclear budding. These nuclear changes have the potential to be used as biomarkers of cell damage in diabetic patients.

Downloads

Download data is not yet available.

Author Biographies

Marcelo Torquato Toneline, PUC-SP

Aluno do curso de Medicina FCMS/PUC-SP

Júlio Boschini Filho, PUC-SP

Professor do Depto. de Morfologia e Patologia da FCMS/PUC-SP.

Débora Aparecida Rodrigueiro, PUC-SP

Professora do Depto. de Morfologia e Patologia da FCMS/PUC-SP.

Neil Ferreira Novo, PUC-SP

Professor do Depto. de Morfologia e Patologia FCMS/PUC-SP.

References

Holland N, Bolognesi C, Kirsch-Volders M, Bonassi S, Zeiger E, Knasmueller S, et al. The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: The HUMN project perspective on current status and knowledge gaps. Mutat Res. 2008;659:93-108.

Bolognesi C, Knasmueller S, Nersesyan A, Thomas P, Fenech M. The HUMNxl scoring criteria for different cell types and nuclear anomalies in the buccal micronucleus cytome assay – An update and expanded photogallery. Mutat Res. 2013;753(2):100-13.

Blasiak J, Arabski M, Hrupa R, Wozniak K, Zadrozny M, Kasznicki J, et al. DNA damage and repair in type 2 diabetes mellitus. Mutat Res. 2004;554:297-304.

Fenech M. Cytokinesis-block micronucleus cytome assay. Nat Protocols. 2007;2:1084-104.

Fenech M, Ferguson LR. Vitamins/minerals and genomic stability in humans. Mutat Res. 2001;475(1):1-6.

Scott D, Burrill W, Barber JBP, Roberts SA, Bulman B. Heritability of chromosomal radiosensitivity in breast cancer patients: a pilot study with the lymphocyte micronucleus assay. Int J Radiat Biol. 2000;76(12):1617-9.

Fenech M, Holland N, Chang W P, Zeiger E, Bonassi S. The Human MicroNucleus Project-an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res. 1999;428:271-83.

Fenech M. Cytokinesis-block micronucleus assay envolves into cytome assay of chromosome instability, mitotic dysfunction and cells death. Mutat Res. 2006;600:58-66.

Martínez-Pérez LM, Cerda-Flores RM, Gallegos-Cabriales EC, Dávila-Rodríguez MI, Ibarra-Costilla E, Cortés-Gutiérrez EI. Frequency of micronuclei in Mexicans with type 2 diabetes mellitus. Prague Med Rep. 2007;108(3):248-55.

Marintim AC, Sanders RA, Watkins JB III. Diabetes, oxidative stress, and antioxidants: a review. JBiochem Mol Toxicol. 2003;17(1):24-38.

Léan ME, Noroozi M, Kelly I, Berns J, Talwar D, Sattar N, et al. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes. 1999;48:176-81.

Kennel WB, Mcgee DI. Diabetes and glucose tolerance as risk factors for cardiovascular diseases. The Farmington study. Diabetes Care. 1979;2:120-6.

Kalapos MP. Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicol Lett. 1999;110(3):145-75.

Dutra F, Bechara EJH, Bioquímica e ação citotóxica de alfa-aminocetonas endógenas. Quim Nova. 2005;28(3):483-91.

Thornalley PJ. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J. 1990;269:1-11.

Çelik A, Diler BB, Eke D. Assessment of genetic damage epithelium cells of painters: micronucleus, nuclear changes, and repair index. DNA Cell Biol. 2010;29(6):277-84.

Thomas P, Holland N, Bolognesi C, Kirsch-Volders M, Bonassi S, Zeiger E, Knasmueller S, Fenech M. Buccal micronucleus cytome assay. Nat Protocols. 2009;4(6):825-37.

Thomas P, Harvey S, Gruner T, Fenech M. The buccal cytome and micronucleus frequency is substantially altered in Down's syndrome and normal ageing compared to young healthy controls. Mutat Res. 2008;638:37-47.

Siegel S, Castellan Jr. NJ. Estatística não paramétrica para ciências do comportamento. 2ª ed. Porto Alegre: ArtMed; 2006.

Friedrisch JR, Pra D, Maluf SW, Bittar CM, Mergener M, Pollo T, et al. DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea. Mutat Res. 2008;649:213-20.

Ceppi M, Biasotti B, Fenech M, Bonassi S. Human population studies with the exfoliated buccal micronucleus assay: statistical and epidemiological issues. Mutat Res. 2009;671(1-2):76-83.

Zúñiga-González GM, Batista-González CM, Gómez-Meda BC, Ramos-Ibarra ML, Zamora-Perez AL, Muñoz-Magallanes T, et al. Micronuclei in diabetes: folate supplementation diminishes micronuclei in diabetic patients but not in an animal model. Mutat Res. 2007;634:126-34.

Salazar AM, Sordo M, Ostrosky-Wegman P. Relationship between micronuclei formation and p53 induction. Mutat Res. 2009;67(2):124-8.

Froguel P, Velho G. Genetic determinants of type 2 diabetes. Recent Prog Horm Res. 2001;56:91-105.

Whiteman M, Hong HS, Jenner A, Halliwell B. Loss of oxidized and chlorinated bases in DNA treated with reactive oxygen species: implications for assessment of oxidative damage in vivo. Biochem Biophys Res Comm. 2002;294:883-9.

Fenech M. Micronutrients frequency and genomic stability: a new paradigm for recommended dietary allowances (RAs). Food Chem Toxicol. 2002;40:1113-7.

Merkel P, Khoury N, Bertolotto C, Perfetti R. Insulin and glucose regulate the expression of the DNA repair enzyme XPD. Mol Cell Endocrinol. 2003;20:175-85.

Fenech M. Micronucleus frequency in human lymphocytes is related to plasma vitamin B12 and homocysteine. Mutat Res. 1999;428:299-304.

Ramirez A, Saldanha PH. Micronucleus investigation of alcoholic patients with oral carcinomas. Genet Mol Res. 2002;1(3):246-60.

Downloads

Published

2014-06-26

How to Cite

1.
Toneline MT, Boschini Filho J, Rodrigueiro DA, Novo NF. Frequency of micronuclei and other nuclear abnormalities in diabetic patients. Rev. Fac. Ciênc. Méd. Sorocaba [Internet]. 2014Jun.26 [cited 2024Jul.18];16(2):80-5. Available from: https://revistas.pucsp.br/index.php/RFCMS/article/view/10896

Issue

Vol. 16 No. 2 (2014)

Section

Original Article

License

Os autores no momento da submissão transferem os direitos autorais, assim, os manuscritos publicados passam a ser propriedade da revista.

O conteúdo do periódico está licenciado sob uma Licença Creative Commons 4.0, esta licença permite o livre acesso imediato ao trabalho e que qualquer usuário leia, baixe, copie, distribua, imprima, pesquise ou vincule aos textos completos dos artigos, rastreando-os para indexação, passá-los como dados para o software, ou usá-los para qualquer outra finalidade legal.